** Toothpaste maker Colgate-Palmolive CL.N forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by weak demand in North America and Latin America for its household products
** Median PT of 24 brokerages covering CL is $100 - LSEG data
RESILIENCE AMID MARKET UNCERTAINTY
** Morgan Stanley ("overweight", PT: $104) expects CL to maintain steady organic sales growth driven by strategic reinvestments, with a positive long-term outlook despite short-term challenges
** J.P. Morgan ("overweight", PT: $97) sees CL achieving moderate growth and improving profitability in 2025, despite facing challenges from currency fluctuations and tariffs
** Morningstar (fairvalue: $84) sees CL to keep investing heavily in R&D and marketing to strengthen its brand, while using strategic price hikes and new product innovations to counter currency impacts
** Stifel ("hold", PT: $93) is cautious about co's near-term performance due to slowing volume growth and market share concerns, despite some expected improvements in gross margin
** Stifel adds that they anticipate more modest gross margin expansion in 2025 compared to 2024, with increased but slowing ad spending
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.